Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Frost & Sullivan Recognizes Suki AI with the 2023 North American Technology Leadership Award
2023-09-12 22:00
TMRW Life Sciences Receives CE Mark for the CryoRobot Select, its Next-Generation Automated Platform to Safely Manage and Store Frozen Eggs and Embryos
2023-09-12 21:01
Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week
2023-09-12 21:00
CSafe Expands Executive Team with Chief Financial Officer
2023-09-12 20:59
Datasea Announces Pricing of $2.0 Million Underwritten Public Offering
2023-09-12 20:30
Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration
2023-09-12 20:00
New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia
2023-09-12 20:00
Metabolon Launches New Biological Stress Discovery Panel to Aid Detection of Inflammation and Biological Stress Biomarkers
2023-09-12 19:57
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA
2023-09-12 19:24
The Korean Society of Ginseng confirms the effects of consuming red ginseng in the prevention and improvement of dementia
2023-09-12 17:00
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
2023-09-12 13:03
Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures
2023-09-12 07:00
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
2023-09-11 21:00
MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities
2023-09-11 19:43
IPMG Drives Health Transformation and Strengthens Indonesia's Economy Through Efforts to Accelerate Access to Innovative Medicines and Vaccines, also Partnerships
2023-09-11 18:52
Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
2023-09-11 15:00
Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
2023-09-11 15:00
Can we really make a difference in reducing the heartbreak of millions of miscarriages each year?
2023-09-11 14:58
Biosyngen received FDA approval for Phase I/II Clinical Trials for BRL03, targeting Lung Cancer, Gastric Cancer and other advanced Solid Tumors
2023-09-11 14:53
PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)
2023-09-11 12:05
1
166
167
168
169
170
980